AstraZeneca Diabetes Drug Shows Promise in Severe Kidney Condition AstraZeneca Diabetes Drug Shows Promise in Severe Kidney Condition
Dapagliflozin has shown promise in a late-stage trial to help to slow chronic kidney disease, putting it on track for possible expanded approvals ahead of rival drugs.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
More News: AstraZeneca | Chronic Kidney Disease | Dapagliflozin | Diabetes | Endocrinology | Forxiga | Health | Urology & Nephrology